Cargando…
Vitamin K antagonist therapy: changes in the treated populations and in management results in Italian anticoagulation clinics compared with those recorded 20 years ago
Vitamin K antagonists (VKA) are the most widely used anticoagulants in the world. An appropriate management of treated patients is crucial for their efficacy and safety. The prospective, observational, multicenter, inception-cohort FCSA-START Register, a branch of START Register (NCT02219984) includ...
Autores principales: | Palareti, Gualtiero, Antonucci, Emilia, Migliaccio, Ludovica, Erba, Nicoletta, Marongiu, Francesco, Pengo, Vittorio, Poli, Daniela, Testa, Sophie, Tosetto, Alberto, Tripodi, Armando, Moia, Marco |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5691104/ https://www.ncbi.nlm.nih.gov/pubmed/28501909 http://dx.doi.org/10.1007/s11739-017-1678-9 |
Ejemplares similares
-
The Italian START-Register on Anticoagulation with Focus on Atrial Fibrillation
por: Antonucci, Emilia, et al.
Publicado: (2015) -
D-dimer testing, with gender-specific cutoff levels, is of value to assess the individual risk of venous thromboembolic recurrence in non-elderly patients of both genders: a post hoc analysis of the DULCIS study
por: Palareti, Gualtiero, et al.
Publicado: (2019) -
Design and rationale of a randomized, placebo-controlled trial on the efficacy and safety of sulodexide for extended treatment in elderly patients after a first venous thromboembolism
por: Palareti, Gualtiero, et al.
Publicado: (2020) -
Bleeding and thrombotic complications during treatment with direct oral anticoagulants or vitamin K antagonists in venous thromboembolic patients included in the prospective, observational START2-register
por: Palareti, Gualtiero, et al.
Publicado: (2020) -
Managing anticoagulation in the COVID-19 era between lockdown and reopening phases
por: Poli, Daniela, et al.
Publicado: (2020)